Depression is widely treatable. That’s the evidence-based clinical reality, and it’s worth saying clearly. But it is also true that a meaningful percentage of people with depression — estimates consistently place it around one in three — do not achieve adequate relief from the first antidepressant they try, or the second, or the third. They’ve followed the treatment plan. They’ve been patient through the trial-and-error of finding the right medication and the right dose. And they still wake up most mornings carrying the same weight they’ve been carrying for months or years.
This is what clinicians call treatment-resistant depression, and it is not a failure of character, of will, or of effort. It is a biological reality: that the brain of one patient responds differently to standard pharmacological intervention than the brain of another, and that some patients need a different mechanism entirely to begin experiencing relief.
TMS therapy — Transcranial Magnetic Stimulation — is one of those different mechanisms. It is available at Cura Mind and Wellness’s Richmond, Texas location, and for patients who have worked through multiple medication trials without adequate results, it represents a clinically meaningful alternative path.
What TMS Therapy Is — and How It Works
Transcranial Magnetic Stimulation uses precisely targeted magnetic pulses to stimulate activity in the regions of the brain associated with mood regulation. The technology was cleared by the FDA for the treatment of major depressive disorder in adults who have not adequately responded to antidepressant medication, and the clinical evidence base supporting its use has grown substantially since that initial clearance.
The treatment works on a simple principle: the prefrontal cortex — the region most consistently underactive in major depression — can be stimulated from outside the skull through magnetic fields that penetrate the brain non-invasively. Unlike electroconvulsive therapy, TMS does not require anesthesia, does not cause seizure, and does not produce the memory effects associated with ECT. The patient sits in a chair, a coil is placed against the scalp, and the magnetic pulses are delivered for a session that typically lasts 20 to 40 minutes. The patient is awake throughout, experiences a tapping sensation at the coil site, and can drive themselves home afterward.
A standard TMS course is typically conducted over four to six weeks, with sessions five days per week. This frequency is not arbitrary — it reflects the mechanism of neuroplasticity that underlies TMS’s effect. The magnetic stimulation provokes activity in underactive neural circuits, and repeated stimulation across multiple sessions strengthens those circuit pathways over time. The improvement is not immediate in the way that some medications produce early sedating or activating effects; it builds across the course of treatment as the targeted brain regions become more consistently active.
Who TMS Is and Isn’t For
TMS is specifically positioned for patients with major depressive disorder who have not responded adequately to antidepressant treatment. In practice, this typically means patients who have tried at least one antidepressant at an adequate dose for an adequate period and have not achieved satisfactory improvement.
TMS is not appropriate for every patient. Individuals who have metal implants in or around the head — cochlear implants, certain types of aneurysm clips, deep brain stimulators — are generally not candidates because the magnetic field could interact with the implant. A thorough evaluation before beginning treatment is the standard of care, and the evaluation at Cura Mind and Wellness is designed to determine candidacy accurately rather than to funnel patients toward any particular modality.
TMS is also not the only option for treatment-resistant depression. IV ketamine therapy — also available at the Richmond location — works through an entirely different mechanism, providing rapid-acting relief through the glutamate system rather than the slower-onset neuroplasticity pathway that TMS engages. For some patients, the appropriate next step after inadequate antidepressant response is TMS; for others, it is ketamine; for others, it is a combination approach or a reassessment of the underlying diagnosis. The evaluation clarifies this.
The Treatment-Resistant Experience — Why It Matters That Someone Finally Has an Answer
For patients who have spent months or years cycling through medication trials, there is often a specific kind of exhaustion that coexists with the depression itself. It is the exhaustion of hoping each new prescription will be the one that works, adjusting to side effects, waiting the weeks for a therapeutic window, and gradually understanding that this one isn’t working either.
When patients arrive at the conversation about TMS, they frequently have a complicated relationship with hope. They’ve hoped before and been disappointed, and a degree of guardedness about treatment optimism is understandable and appropriate.
Vivian Emuobe, DNP, APRN, PMHNP-BC, is a board-certified psychiatric nurse practitioner who brings a clinical background that spans inpatient and outpatient psychiatric settings across Massachusetts and Texas. Her role as Director of the Women Program and the Women of Color PHP Program at HRI Hospital in Massachusetts reflects the depth of her experience with patients whose mental health needs are complex, layered, and not well served by surface-level treatment. She approaches the treatment-resistant depression conversation as what it is: a clinical challenge that deserves clinical rigor, not platitudes.
The evaluation that precedes any recommendation about TMS at Cura Mind and Wellness is thorough precisely because the patients who arrive at this point have already had experiences with treatments that were recommended without sufficient individualization. Understanding a patient’s full psychiatric history, their medication trials, their current symptom picture, and any factors that might affect candidacy or modify the treatment approach takes time — and that time is considered an investment in getting the recommendation right, not an obstacle to starting quickly.
What Improvement Can Look Like
TMS response is not uniform across patients, and responsible clinical communication about TMS does not overstate what the treatment reliably delivers. What the clinical literature consistently shows is that a meaningful percentage of patients who complete a TMS course experience significant reduction in depressive symptoms, and a subset experience full remission. These are not trivial findings for a population that has already found standard treatments inadequate.
The improvement, when it occurs, tends to be characterized by patients as a gradual lifting — a return of energy, of interest, of the ability to engage with daily life in ways that had become difficult or impossible. The flattened emotional landscape that depression produces begins to develop texture again. The tasks that required enormous effort become more manageable.
For patients who have lived with treatment-resistant depression for years, this kind of incremental change is not a disappointment. It is often described as the first time in a long time that something has actually worked.
Access TMS Therapy at Cura Mind and Wellness in Richmond, TX
TMS therapy is available at the Richmond, Texas location of Cura Mind and Wellness at 20711 Bellaire Boulevard, Suite B. Cura Mind and Wellness also serves patients across Texas through telehealth for medication management, psychotherapy, and evaluation services, with TMS requiring the in-person Richmond setting.
Call (281) 939-9566 to schedule an evaluation for the Richmond office, or reach the general line at (617) 777-7982. If you have been working with your mental health care — and working hard — without the results you need, an evaluation at Cura Mind and Wellness is the right place to ask whether TMS is the appropriate next step for you specifically.
Posted on behalf of